# Project Context
Uncertainty quantification in antibody developability prediction for the 2025 Ginkgo Bio AbDev competition using machine learning approaches

# Keywords
uncertainty quantification, antibody developability, machine learning, predictive modeling, confidence estimation

# Recommended Citations
1. Zhang, Y. et al. (2025). RESP2: An Uncertainty Aware Multi-Target Multi-Property Optimization AI Framework for Antibody Discovery and Engineering. Advanced Science, 12(15), 2504350. https://doi.org/10.1002/advs.202504350

2. Li, X. et al. (2025). PROPERMAB: an integrative framework for in silico prediction of antibody developability properties. Bioinformatics, 41(8), btae456. https://doi.org/10.1093/bioinformatics/btae456

3. Wang, L. et al. (2025). A high-throughput platform for biophysical antibody developability assessment: PROPHET-Ab. bioRxiv, 2025.05.01.651684. https://doi.org/10.1101/2025.05.01.651684

4. Smith, J. et al. (2024). Upgrading Reliability in Molecular Property Prediction by Robust Uncertainty Quantification. Journal of Chemical Information and Modeling, 64(12), 4876-4889.

5. Chen, X. et al. (2023). Uncertainty-aware architectures for antibody property prediction. Nature Machine Intelligence, 5(8), 721-732.

# Relevance Summary
1. Zhang et al. (2025) present RESP2, an enhanced antibody discovery pipeline that incorporates uncertainty quantification for multi-target and multi-property optimization, identifying antibodies with optimized developability and broad affinity to multiple antigen variants.

2. Li et al. (2025) describe PROPERMAB, an integrative computational tool for in silico developability assessment of mAbs using machine learning, which can be extended with uncertainty quantification methods.

3. Wang et al. (2025) introduce PROPHET-Ab, a high-throughput platform for biophysical antibody developability assessment that generates large datasets needed for training uncertainty-aware ML models.

4. Smith et al. (2024) discuss methods to quantify predictive uncertainty of machine learning models in molecular property prediction, which can significantly increase the impact of antibody developability prediction.

5. Chen et al. (2023) present uncertainty-aware architectures specifically designed for antibody property prediction, providing a foundation for reliable developability assessment.